BusinessPostCorner.com
No Result
View All Result
Monday, July 7, 2025
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
BusinessPostCorner.com
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
No Result
View All Result
BusinessPostCorner.com
No Result
View All Result

Saxenda is latest weight loss drug facing a shortage

July 19, 2023
in Business
Reading Time: 1 min read
A A
0
Saxenda is latest weight loss drug facing a shortage
ShareShareShareShareShare

Novo Nordisk’s drug Saxenda is the latest to hit a shortage, as high demand for weight loss drugs sparks supply snags across the industry.

Saxenda will have limited availability through the end of the year, according to a notice posted Tuesday on a US Food and Drug Administration database.

On a consumer-facing website for the drug, the company said it is still making and shipping Saxenda but warned of issues filling prescriptions “for the remainder of 2023 and beyond.” 

“We continue to see demand for Saxenda increase at a substantial rate, resulting in supply interruptions,“ a Novo spokesperson said in an email. 

Newer drugs from Novo Nordisk like Wegovy and Ozempic, as well as Eli Lilly & Co.’s diabetes drug Mounjaro, have become hugely popular in recent months after studies showed they could help patients lose dozens of pounds. Only Wegovy is approved by the FDA to treat obesity.

While Saxenda works similarly to these new drugs, it’s less effective and helps patients lose less weight. Recent shortages of Wegovy and Mounjaro, however, have led to renewed interest. Prescriptions for Saxenda jumped nearly 30,000 between May 2023 and June 2023, according to Bloomberg Intelligence data, the biggest monthly jump over the past two years. 

On a Novo website for Wegovy, the company warns prospective patients against switching to Saxenda, saying “we cannot guarantee supply to match the continuous rising demand for weight management medications.”

Credit: Source link

ShareTweetSendPinShare
Previous Post

Partnership, Technology And Trust Provide The Key For Speakers Bureaus To Win

Next Post

Live news: Johnson & Johnson sues US government over drug price controls

Next Post
Live news: Johnson & Johnson sues US government over drug price controls

Live news: Johnson & Johnson sues US government over drug price controls

Trump’s tax bill passes Senate as Republicans notch major win

Trump’s tax bill passes Senate as Republicans notch major win

July 1, 2025
“I’m Most Excited About Stock Tokens, As We Can Use Crypto For More Than Trading Assets,” Says Robinhood Crypto GM

“I’m Most Excited About Stock Tokens, As We Can Use Crypto For More Than Trading Assets,” Says Robinhood Crypto GM

July 1, 2025
North Korean operatives and American accomplices accused in massive fraud that infiltrated the Fortune 500 and stole millions

North Korean operatives and American accomplices accused in massive fraud that infiltrated the Fortune 500 and stole millions

June 30, 2025
UK-US tariff deal begins but still no news on steel

UK-US tariff deal begins but still no news on steel

June 30, 2025
Russian Ministry Starts Compiling National Registry of Crypto Mining Rigs

Russian Ministry Starts Compiling National Registry of Crypto Mining Rigs

July 6, 2025
Trump announces US-Vietnam trade deal

Trump announces US-Vietnam trade deal

July 2, 2025
BusinessPostCorner.com

BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!

Recent News

Trump calls Musk’s new political party plan ‘ridiculous’

Trump calls Musk’s new political party plan ‘ridiculous’

July 7, 2025
Russian Ministry Starts Compiling National Registry of Crypto Mining Rigs

Russian Ministry Starts Compiling National Registry of Crypto Mining Rigs

July 6, 2025

Our Newsletter!

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2023 businesspostcorner.com - All Rights Reserved!

No Result
View All Result
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources

© 2023 businesspostcorner.com - All Rights Reserved!